pp-211 Cutaneous spray

China

"Indication: Secondary wound infections in diabetic foot ulcers (Wagner Grade 2), burns, and traumatic wounds Clinical stage: Phase 3 completed — confirmatory Phase 3 results published (570 patients, 37 China hospitals) Modality: Biological (novel antimicrobial peptide — NBE) Mechanism / Target: Broad-spectrum antimicrobial peptide (AMP); disrupts bacterial cell membrane integrity via electrostatic membrane binding and pore formation; bactericidal against resistant gram-positive and gram-negative organisms (including MRSA, MDR-GN) in complex wounds Route / form: Topical spray Differentiation: Novel antimicrobial peptide with superior efficacy over traditional antibiotics for drug-resistant wound pathogens; Phase 3 confirmatory results published; addresses critical unmet need in diabetic foot/MDR wound infections;